Gonzalez Lilah C MD is categorized under Proprietary (Patent) Medicines, Nec in Berlin, MD and active since 1994.
Gonzalez Lilah C MD was established in 1994, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Proprietary (Patent) Medicines, Nec business, which does work in the B2B market, and is classified as a Proprietary (Patent) Medicines, Nec, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Lilah Gonzalez at the company’s single location by writing to 314 Franklin Avenue # 104, Berlin, Maryland MD 21811 or by phoning (410) 641-2696. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Gonzalez Lilah C MD |
| Contact Person: | Lilah Gonzalez |
| Address: | 314 Franklin Avenue # 104, Berlin, Maryland 21811 |
| Phone Number: | (410) 641-2696 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1994 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Proprietary (Patent) Medicines, Nec |
| SIC Code: | 5122 |
| NAICS Code: | 6211110 |
| Share This Business: |
Gonzalez Lilah C MD was started in 1994 to provide professional Proprietary (Patent) Medicines, Nec under the SIC code 5122 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Lilah Gonzalez for inquiries that concern Gonzalez Lilah C MD by calling the company number (410) 641-2696, as your correspondence is most welcome. Additionally, the physical location of the single location of Gonzalez Lilah C MD can be found at the coordinates 38.330267,-75.213294 as well as the street address 314 Franklin Avenue # 104 in Berlin, Maryland 21811.
For its online presence, you may visit Gonzalez Lilah C MD’s website at and engage with its social media outlets through on Twitter and on Facebook.